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The ability of the atria1 wall to secrete atria1 natriuretic 
peptide was studied in eight dogs during 2 h of cardiac 
tamponade and for 2 h after decompression of the pericar- 
dium. Cardiac tamponade was induced by instillation of 
5% dextrose in water into the pericardial cavity until aortic 
systolic pressure was reduced by 30% to 35%. Heart rate, 
cardiac output and atrial, pericardial and aortic pressures 
were measured at 60 and 120 min of tamponade and at 5, 
30,60,90 and 120 min after decompression. Blood samples 
were withdrawn at the same time for the determination of 
atria1 natriuretic peptide and aldosterone levels. 
Aortic pressure decreased significantly during tampo- 
nade and increased after decompression to near control 
levels. Right and left atria1 pressures as well as intraperi- 
cardial pressure increased significantly during tamponade 
and returned to control levels after decompression. The 
effective transmural pressure, which was reduced during 
tamponade, was increased significantly at 5 min after 
decompression. Cardiac output was significantly reduced 
during tamponade and returned to pretamponade levels 
after decompression. Over the total experimental period, 
no significant changes in the levels of atrial natriuretic 
peptide were observed, whereas aldosterone increased sig- 
nificantly. 
It is concluded that the increased atria1 pressure ob- 
served during cardiac tamponade did not stimulate the 
secretion of atria1 natriuretic peptide. Furthermore, atria1 
distension observed immediately after decompression was 
not sufficient or of long enough duration to induce measur- 
able increases in atria1 natriuretic peptide levels. Finally, 
the secondary hyperaldosteronism did not activate atria1 
natriuretic peptide secretion either during cardiac tampo- 
nade or after decompression. 
(J Am Co11 Cardiol1989;13:936-40) 
It is well known that, in the atria1 wall, there are receptors 
sensitive to mechanical and chemical stimuli that respond 
with a greater or lesser neurohumoral discharge (1). An 
increase in the atria1 pressure or distension of the atria1 wall 
has been shown to cause natriuresis and diuresis (2-4), thus 
supporting the concept that changes in atria1 pressure are 
important in the sequence of events regulating the circulating 
blood volume (5). 
Recently, attention has been focused on the findings of de 
Bold et al. (2), who reported that mammalian atria1 cells 
contain and secrete a potent natriuretic substance that was 
initially considered to be a 28 amino acid peptide (6,7). 
Further studies (8,9) support the fact that it is an atrial 
natriuretic peptide made up of 3 1 to 33 amino acid residues. 
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Atria1 dilation, which is the common denominator of all 
these conditions, probably results in excitation of stretch 
receptors and, thus, constitutes a secretory stimulus for 
atria1 natriuretic peptide (20,21,25,26). The nature of this 
atrial stimulus is not yet completely clarified, but it is known 
that an increase in right and left atria1 pressure beyond 
normal levels is capable of inducing atria1 natriuretic peptide 
secretion (21). In cardiac tamponade of short duration (530 
min), in which atria1 pressure is increased without concur- 
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This atria1 peptide has a natriuretic and vasodilative action 
and a suppressive effect on the renin-angiotensin-aldo- 
sterone axis (3,10-14). Although detailed knowledge of this 
peptide has been limited, it has been found to circulate in the 
blood of human subjects under normal and abnormal condi- 
tions (U-18) and to exist in increased concentrations in 
patients with paroxysmal supraventricular tachycardia, pri- 
mary hyperaldosteronism, mitral valve stenosis, car pulmo- 
nale, congestive heart failure, chronic renal failure with fluid 
retention and states with increased circulating blood volume 
(15,16,1&24). 
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rent distension of the atrium, the atrial natriuretic peptide fused to replace the volume of blood sampled. Atrial natri- 
level is not increased (27,28). It was also reported (29) in one uretic peptide was measured in plasma with the Amersham 
clinical case that plasma atrial natriuretic peptide levels radioassay kit and aldosterone levels with a Sorin Aldoctk 
increased after decompression of cardiac tamponade. assay kit. 
The present .ctrrdy mttrmpted to um’er lhe ,folht~ir~g 
yrr~sfims: I ) Can atrial wall distension, observed at the time 
of decompression. cause the secretion of atrial natriuretic 
peptide? 2) Can the secondary hyperaldosteronism consti- 
tute a stimulus to atrial natriuretic peptide secretion during 
or after cardiac tamponade? 3) Does increased atrial pres- 
sure without dilation of the atrial wall during a 2 h period of 
cardiac tamponadc raise plasma atrial natriuretic peptide 
levels’.’ 
Statistics. Statistical analysis of all data was performed 
with use of the Student’s t test for paired data. Values are 
presented as mean I SEM. 
The study with the experimental animals conformed to 
the position of the American Heart Association on research 
animal use. 
Results 
Methods 
Animal preparation. Eight healthy mongrel dogs of either 
sex, weighing between 12 and I5 kg, were studied. Thirty 
minutes before operation, the dogs were premeditated with 
acepromazine (0.5 mgikg body weight) and atropine (0.05 
mgikg). Anesthesia was induced with sodium thiopental (20 
mgikg). An endotracheal tube was placed and connected to a 
volume-controlled respirator that supplied the dog with 
room air. To provide a stable anesthetic state. supplemen- 
tary doses of thiopental were given throughout the experi- 
ment. Appropriate limb leads were attached to the dog fat 
continuous electrocardiographic (ECG) monitoring. Correc- 
tions in ventilation and acid-base balance were made to keep 
homeostasis within normal limits. 
Surgical procedure. A right thoracotomy was performed 
through the fifth intercostal space. A Foley catheter was 
inserted into the pericardium and secured by a double 
pursestring suture. For continuous monitoring of central 
aortic and right and left atria1 pressures, catheters were 
placed through the carotid artery, the azygos vein and a 
branch of a right pulmonary vein. Cardiac output was 
measured by the thermodilution technique with use of a 
SwanGanz catheter inserted through the jugular vein into 
the pulmonary artery. Blood samples were taken from the 
catheter in the right atrium for determination of atrial natri- 
uretic peptide and aldosterone. 
Tamponade. Cardiac tamponade was induced by the 
instillation of a solution of dextrose in water at 37°C into the 
pericardial sac over 5 min until aortic systolic pressure was 
reduced by 30% to 35%. The tamponade was maintained for 
2 h, adding more dextrose to maintain the same level of 
aortic pressure. The pericardium was then released by rapid 
drainage of the fluid. 
Measurements and blood sampling. All hemodynamic 
variables were recorded before, at 60 and 120 min of 
tamponade and at 5. 30. 60, 90 and 120 min after the release 
of tamponade. Blood samples were simultaneously taken 
from the right atrium for natriuretic peptide and aldosterone 
determinations. An equal volume of 5% dextrose was in- 
Detailed results of all measured variables during the 
different phases of the study are presented in Table I. 
Hemodynamic variables. Aortic systolic pressure de- 
creased significantly during the 2 h of tamponade. After 
decompression of the pericardial sac, a significant increase 
in aortic pressure was observed. However, arterial pressure 
remained at significantly lower levels compared with control 
values. 
Mcrrrl righlhr trtrial pressure increased significantly during 
tamponade and returned to control levels with decompres- 
sion. Similar changes in mean left atrial pressure were 
observed. although absolute values were higher than those 
for the right atrium. 
_Ejf?cfi\v trcrnsmwrrl pressurr 01’ rhs atria, calculated as 
the difference between mean atrial and pericardial pressures, 
decreased significantly during tamponade and increased to 
the pretamponade level after decompression of the pericar- 
dium. 
D//ring tnmponrdc, a significant decwa.se in urrdiac 
indrx NW ohserwd. After the removal of fluid from the 
pericardium, the cardiac index initially increased and then 
gradually declined to levels significantly lower than control. 
Herrrt rrrtr showed a continuous decrease with the onset 
of tamponade. which became significant after 120 min. 
Hormone levels. Right atrial aldosterone concentration 
increased by almost 400% during tamponade. In the period 
after removal of pericardial fluid, aldosterone concentration 
decreased gradually, although values remained significantly 
higher than control values. Changes in atrial natriuretic 
peptide levels were not significant during tamponade and 
after decompression of the pericardium. 
Discussion 
Atrial natriuretic peptide and atria1 pressure. Mammalian 
atrial cells contain granules resembling those of endocrine 
organs (12,30.3 I). The number of these granules is directly 
proportional to salt load and blood volume (32). Although 
the muscle cells of both the right and the left atrium contain 
natriuretic peptide-secreting granules. these are found in 
twice the concentration in the tissue of the right atrium 
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Table 1. Results of Measured Variables (mean + SEM) in Eight Dogs 
Tamponade (min) 
Before 60 120 5 30 
Decompression (min) 
60 90 120 
Systolic 
aortic 
(beatsimin) 
Aldosterone 
pressure 
(mm Hg) 
Mean right 
atria1 
pressure 
(mm Hg) 
Mean left 
atria1 
pressure 
(mm Hg) 
(pmol/ml) 
ANP 
Pericardial 
pressure 
(mm Hg) 
Cardiac 
output 
index 
(mlimin 
per kg) 
Heart rate 
(fmoliml) 
151.50 r 4.17 101.50 t 2.58* 104.00 ? 3.96* 140.00 ? 8.01*1 135.25 L 4.63* 131.62 + 6.63* 130.62 ? 7.65* 129.50 k 6.70* 
3.32 r 0.47 10.05 i 1.02* 9.06 f 0.93* 3.81 ” 0.72t 2.97 + 0.57 2.83 ? 0.50 2.88 + 0.57 2.62 ? 0.47 
4.87 2 0.71 10.14? 1.06* 9.76 ” 0.97* 5.11 k 0.62+ 4.80 ? 0.51 4.75 r 0.52 4.91 ? 0.45 4.31 ? 0.49+ 
0 9.08 k 0.95 7.89 + 0.73 0 0 0 0 0 
120 ? 9 60 2 IO* 60 t 7* 130 ? 9t 120 5 8 II0 t IO 90 ? 7* 90 2 8* 
151.25 ? 5.57 148.37 + 5.10 
84.50 
126.00 t 8.3l*t 
+ 22.98 333.25 + 77.81* 281.37 t 58.53* 
18.30 t 4.58 26.41 + 6.24 23.83 + 5.78 
110.25 ? 7.17*1 115.87 + 10.67* 114.37 + ll.lO* 113.50 ? 10.91* 109.12 f 10.24* 
234.75 + 57.75* 176.00 ? 42.14*+ 165.50 5 35.78” 155.62 + 37.13* 157.25 k 35.57* 
26.10 ? 5.71 28.41 + 6.06 20.49 + 4.45 17.81 + 5.45 18.52 k 4.76 
*p < 0.05 compared with control; tp < 0.05 compared with preceding phase. ANP = atrial natriuretic peptide. 
(33,34). Also, in addition to its own secretion, the right 
atrium receives from the left atrium, natriuretic peptide, 
returning through the coronary sinus (18). 
In an isolated heart model, Lang et al. (20) showed that 
for each 1 mm Hg increase in right atria1 pressure, the level 
of atria1 natriuretic peptide in plasma increased by 38%. 
Also, in a clinical study, Raine et al. (21) showed that when 
right atrial pressure was increased by 1 mm Hg above the 
level of 4 mm Hg, the concentration of atrial natriuretic 
peptide in plasma increased by 36%. Rapid infusion of either 
sodium chloride solution or whole blood produced an in- 
crease in the plasma level of atria1 natriuretic peptide. 
However, the peak concentration of the secreted hormone 
occurred much earlier when expansion was obtained with 
sodium chloride than with whole blood (20,35). Also hemo- 
dynamic studies in healthy humans (23) and patients with 
congestive heart failure (21) showed a linear relation be- 
tween atria1 natriuretic peptide concentration and atria1 
pressure. 
Atria1 natriuretic peptide during cardiac tamponade. Our 
present results confirm findings of other workers, cast light 
on some of the existing questions and leave open some 
topics that could stimulate further research. During the first 
2 h of tamponade, there was no significant increase in atrial 
natriuretic peptide (Fig. 1). It seems that the increase in 
atrial pressure by itself is not sufficient to stimulate secretion 
of the peptide and that dilation caused by a pressure gradient 
across the atria1 wall is also necessary (20-23,262s). This 
hypothesis is supported by our finding that the effective 
transmural pressure was significantly reduced in both atria 
during tamponade (Fig. 2). 
The secondury hyperaldosteronism we observed during 
the period of tamponade does not seem to be a potent 
stimulus for secretion of atrial natriuretic peptide (Fig. 3). 
We postulate that this stimulus of 2 h of tamponade is of 
Figure 1. Changes in atrial natriuretic peptide plasma levels before 
and during cardiac tamponade and after decompression. 
z 51 SEM 
L 
NS = p>O.O5 
60 120 5 30 60 90 120 min 
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Figure 2. Changes in effective atrial transmural pressure before and 
during cardiac tamponade and after decompression. *p < 0.05 
compared with control values: +p < 0.05 compared with tamponade 
values. Lt = left: Kt = right. 
insufficient duration to promote secretion of this peptide. 
Furthermore, in cardiac tamponade, a reduction in sensitiv- 
ity and secretory capacity of the mechanical and humoral 
receptors may exist because of the reduced pressure gradi- 
ent across the atrial wall or because of the reduced circulat- 
ing blood volume (I .27,28). In addition, it is possible that 
exposure of the receptors for a long period of time to 
increased intracavitary pressure without distension may lead 
to a reduction in their sensitivity. 
Car&c olrtput IIYI.S reduced it2 our study by 50% during 
turrzporudr. This was expected to be compensated by an 
elevation in heart rate. peripheral vasoconstriction and myo- 
cardial contractility (36). However, we observed in the 2nd h 
a reduction in heart rate that was statistically significant. 
This decrease was in accordance with the findings of other 
investigators (37-39) and was probably related either to the 
choice of anesthesia or to increased parasympathetic tone. 
Atrial natriuretic peptide after pericardial decompression. 
After the removal of pericardial fluid. we anticipated in- 
creased levels of atrial natriuretic peptide caused by I) the 
elevated effective transmural pressure of the atrial wall: 2) 
the dilation of the atrial wall induced by an increased venous 
return: and 3) the high levels of aldosterone (l9-21,26.29). 
Figure 3. Changes of aldosterone plasma levels before and during 
cardiac tamponade and after decompression. 
450 
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I 
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Decompression 
However. plasma atrial natriuretic peptide failed to increase 
significantly above the control and tamponade levels. A 
possible explanation might be that, although after decom- 
pression atrial pressures returned to levels slightly above 
control levels, the difference in pressure between the two 
phases of the experiment was not greater than 1 mm Hg 
(20.21). On the other hand, if it is accepted that, immediately 
after decompression, pressure in the atria had increased for 
<5 min when the first pressure recording was made, this 
duration might be insufficient to stimulate secretion of the 
peptide (20.21.25.26). Finally, another explanation for the 
unresponsiveness of the receptors might be the loss of their 
sensitivity or activity, or both. which occurred during tam- 
ponade. 
The increase in venous return that resulted in an aug- 
mented stroke volume and cardiac output did not constitute 
a secreting stimulus for the atria1 natriuretic peptide. These 
changes, however. were not statistically significant except 
for stroke volume, which was increased by 39% and 26% at 
5 and 30 min. respectively. Perhaps a prerequisite for the 
release of atrial natriuretic peptide might be a significant 
increase in circulating blood volume in the atria beyond the 
pretamponade values (20.21). It is also possible that the 2 h 
duration of tamponade is too short to allow the atrial 
receptors to become reset to the new hemodynamic condi- 
tions ( 1,291. Finally, it is apparent that aldosterone, although 
significantly increased. was not able to stimulate a similar 
secretion of atrial natriuretic peptide in plasma. 
Conclusions. Cardiac tamponade of 2 h duration does not 
significantly increase atrial natriuretic peptide levels in 
blood. This finding might be explained by the absence of an 
elevated effective transmural pressure. which seems to be a 
prerequisite for the activation of stretch receptors. After 
decompression of the pericardial sac, no increase in the 
atrial natriuretic peptide level occurred despite the increase 
in the effective transmural pressure because either the in- 
crease was not much greater than the control level or it 
lasted for a very short period of time. It is also postulated 
that the duration of cardiac tamponade may not have been 
sufficient for the stretch receptors to become readjusted to 
the new conditions. It seems also that the elevated plasma 
levels of aldosterone are not a potent stimulus for the 
secretion of atrial natriuretic peptide either during acute 
tamponade or after decompression of the pericardial sac. 
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